Title |
Single dose oral nefopam for acute postoperative pain in adults
|
---|---|
Published in |
Cochrane database of systematic reviews, July 2009
|
DOI | 10.1002/14651858.cd007442.pub2 |
Pubmed ID | |
Authors |
Manish Kakkar, Sheena Derry, R Andrew Moore, Henry J McQuay |
Abstract |
Nefopam is a centrally-acting but non-opioid analgesic drug of the benzoxazocine chemical class, developed in the early 1970s. It is widely used, mainly in European countries, for the relief of moderate to severe pain as an alternative to opioid analgesic drugs, and used in rheumatic disease and other musculoskeletal disorders in the UK. This review sought to evaluate the efficacy and safety of oral nefopam in acute postoperative pain, using clinical studies of patients with established pain, and with outcomes measured primarily over 6 hours using standard methods. This type of study has been used for many decades to establish that drugs have analgesic properties. |
Twitter Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 67 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 9 | 13% |
Researcher | 8 | 12% |
Student > Bachelor | 5 | 7% |
Other | 4 | 6% |
Student > Doctoral Student | 3 | 4% |
Other | 9 | 13% |
Unknown | 29 | 43% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 18 | 27% |
Nursing and Health Professions | 8 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
Psychology | 3 | 4% |
Biochemistry, Genetics and Molecular Biology | 1 | 1% |
Other | 4 | 6% |
Unknown | 30 | 45% |